|
KIAA1731 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.0037999955197E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.42690000004553E-06 |
| Normal-vs-Stage2 |
1.95520000001448E-06 |
| Normal-vs-Stage3 |
1.62370000000855E-06 |
| Normal-vs-Stage4 |
6.45929999999462E-05 |
| Stage1-vs-Stage2 |
7.985700E-02 |
| Stage1-vs-Stage3 |
2.856600E-01 |
| Stage1-vs-Stage4 |
5.126800E-01 |
| Stage2-vs-Stage3 |
4.065400E-01 |
| Stage2-vs-Stage4 |
3.863800E-01 |
| Stage3-vs-Stage4 |
8.852200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.80800000316017E-08 |
| Normal-vs-AfricanAmerican |
3.472400E-02 |
| Normal-vs-Asian |
2.379600E-03 |
| Caucasian-vs-AfricanAmerican |
2.015200E-01 |
| Caucasian-vs-Asian |
2.164000E-01 |
| AfricanAmerican-vs-Asian |
7.535400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.30130000000007E-05 |
| Normal-vs-Female |
2.65890000017421E-08 |
| Male-vs-Female |
4.045000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.39930000000199E-05 |
| Normal-vs-Age(41-60Yrs) |
1.1816000000664E-07 |
| Normal-vs-Age(61-80Yrs) |
1.29029999995645E-06 |
| Normal-vs-Age(81-100Yrs) |
2.047100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.355200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.022000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.704300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.180400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.548100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.327800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.948400E-02 |
| Classical-VS-Follicular |
7.014200E-01 |
| Classical-VS-Other |
3.726200E-01 |
| Classical-VS-Normal |
1.20290000005241E-06 |
| Tall-VS-Follicular |
2.343600E-01 |
| Tall-VS-Other |
5.612000E-02 |
| Tall-VS-Normal |
1.3948000000541E-06 |
| Follicular-VS-Other |
3.940200E-01 |
| Follicular-VS-Normal |
1.775690E-04 |
| Other-VS-Normal |
3.297200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.19940000153917E-08 |
| Normal-vs-N1 |
9.843100E-03 |
| N0-vs-N1 |
8.943600E-02 |
|
|
